Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1613, 2007-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No bones about the cost effectiveness of zoledronic acid
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Access to resources
Recommend
Make no bones about alendronic acid
Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. :
Zoledronic acid cost effective in preventing AI-associated bone loss
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. :
Zoledronic acid to prevent SREs in prostate, renal cancer cost effective
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 578, 2009-01 ,pp. :
Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. :